BioCentury
ARTICLE | Management Tracks

Investment banking vet Lang becomes CFO at Aerie

Plus Mission names Essig chair, and updates from enGene, NRx, Capsulomics

March 18, 2022 11:46 PM UTC

Ophthalmic disorder company Aerie Pharmaceuticals Inc. (NASDAQ:AERI) hired Peter Lang as CFO. Lang joins from Ridge Advisory LLC, where he was managing director and partner. He previously held healthcare banking roles at HSBC, FBR & Co., Leerink Partners and Bank of America Merrill Lynch. Lang replaces interim CFO Christopher Staten, who resigned last October. The company’s CEO left the prior month following disappointing Phase II data. 

Single-cell DNA and multi-omics company Mission Bio Inc. appointed Stuart Essig to chair its board. Essig is a director of several life sciences companies, including Integra LifeSciences Holdings Corp. (NASDAQ:IART), SeaSpine Holdings Corp. (NASDAQ:SPNE) and Idexx Laboratories Inc. (NASDAQ:IDXX)...